ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
WESTMINSTER, Colo., May 05, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO) today announced…
News
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
– Patient enrollment completed in Arm A in the Phase 2 study of praluzatamab ravtansine…
Certara Reports First Quarter 2022 Financial Results
PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Idera Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
EXTON, Pa., May 05, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,”…
Aileron Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
On track to report interim results from Phase 1b clinical trial of ALRN-6924 in patients…
Calyxt, Inc., Cellectis’ Majority-Owned Subsidiary, Reports Its First Quarter 2022 Financial Results
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ:…
NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results
Initiated Phase 1/1b clinical trial of NGM831, an ILT3 antagonist antibody product candidate, as a…
Pharvaris to Participate in BofA Securities 2022 Healthcare Conference
ZUG, Switzerland, May 05, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company developing…
PacBio to Participate in the BofA Securities 2022 Healthcare Conference
MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) — PacBio announced today that it will…
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2022 Financial Results
– $1.2 billion of sotrovimab collaboration revenue recognized in the first quarter – – More…
Apellis Pharmaceuticals to Present at the Bank of America Securities 2022 Healthcare Conference
WALTHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
Signs definitive merger agreement with Cend Therapeutics along with immediate investment and collaboration agreements Maintains…
Ventyx Biosciences to Report First Quarter 2022 Financial Results on May 12, 2022
ENCINITAS, Calif., May 05, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a…
Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., May 05,…
Codexis Reports First Quarter 2022 Financial Results
Total Revenue up 96% and Product Revenue up 200% YOY; Product Gross Margin Expands to…
Celyad Oncology Announces First Quarter 2022 Financial Results and Recent Business Highlights
Enrollment continues in Phase 1 dose-escalation IMMUNICY-1 trial for lead shRNA-based allogeneic CAR T candidate,…
LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference
SHANGHAI, China and PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
T2 Biosystems Announces First Quarter 2022 Financial Results
Results driven by strong sepsis-focused instrument placements in the United States LEXINGTON, Mass., May 05,…
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
Q1 2022 revenue $16.9 million, 38% growth over prior year periodRaising FY 2022 revenue guidance…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
Corvus to Host R & D Symposium on May 10 BURLINGAME, Calif., May 05, 2022…